Clover Health Investments (CLOV) Stock Forecast & Price Target $4.58 -0.21 (-4.38%) Closing price 10/29/2026 04:00 PM EasternExtended Trading$4.57 -0.01 (-0.24%) As of 07:42 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Clover Health Investments - Analysts' Recommendations and Stock Price Forecast (2026) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating HoldBased on 7 Analyst RatingsSell1Hold3Buy3 Based on 7 Wall Street analysts who have issued ratings for Clover Health Investments in the last 12 months, the stock has a consensus rating of "Hold." Out of the 7 analysts, 1 has given a sell rating, 3 have given a hold rating, and 3 have given a buy rating for CLOV. Consensus Price Target $5.009.17% Upside According to the 7 analysts' twelve-month price targets for Clover Health Investments, the average price target is $5.00. The highest price target for CLOV is $6.00, while the lowest price target for CLOV is $2.50. The average price target represents a forecasted upside of 9.17% from the current price of $4.58. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for CLOV and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Clover Health Investments and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLOV Analyst Ratings Over TimeTypeCurrent Forecast10/30/25 to 10/30/261 Month Ago9/30/25 to 9/30/263 Months Ago8/1/25 to 8/1/261 Year Ago10/30/24 to 10/30/25Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)1 Strong Buy rating(s)Buy3 Buy rating(s)2 Buy rating(s)1 Buy rating(s)2 Buy rating(s)Hold3 Hold rating(s)3 Hold rating(s)3 Hold rating(s)2 Hold rating(s)Sell1 Sell rating(s)1 Sell rating(s)1 Sell rating(s)1 Sell rating(s)Consensus Price Target$5.00$4.75$4.25$4.03Forecasted Upside9.17% Upside10.21% Upside1.92% Upside15.99% UpsideConsensus RatingHoldHoldHoldModerate Buy CLOV Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History CLOV Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Clover Health Investments Stock vs. The CompetitionTypeClover Health InvestmentsHealthcare CompaniesBroader MarketConsensus Rating Score 2.29 2.33 2.52Consensus RatingHoldHoldModerate BuyPredicted Upside9.17% Upside107.08% Upside15.05% UpsideNews Sentiment RatingPositive NewsSee Recent CLOV NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings Most Recent from Each Brokerage All Show All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action 10/30/2024 - 10/30/2026 Report Date Report Date From Report Date To 1M3M6MYTD1Y2Y3Y5Y More filters Fewer filters Done 0 Results Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails10/28/2026 Needham & Company LLC4 of 5 starsMatthew SheaNot RatedInitiated CoverageBuy$6.00+29.59%9/21/2026 Weiss Ratings2 of 5 stars Reiterated RatingSell (D-)9/14/2026 Zacks Research4 of 5 stars UpgradeHold9/10/2026 Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access to unlock brokerage rankings Initiated CoverageBuy$6.00+38.25%8/6/2026 UBS GroupSubscribe to MarketBeat All Access to unlock brokerage rankingsJonathan YongSubscribe to MarketBeat All Access to unlock analyst rankingsBoost TargetNeutral$4.75 ➝ $5.00-1.44%7/21/2026 Canaccord Genuity GroupSubscribe to MarketBeat All Access to unlock brokerage rankingsRichard CloseSubscribe to MarketBeat All Access to unlock analyst rankingsBoost TargetBuy$4.20 ➝ $5.50+22.22%3/5/2026 Leerink PartnersSubscribe to MarketBeat All Access to unlock brokerage rankingsWhit MayoSubscribe to MarketBeat All Access to unlock analyst rankingsLower TargetMarket Perform$3.00 ➝ $2.50+21.36%12/17/2024 Craig HallumSubscribe to MarketBeat All Access to unlock brokerage rankingsMatthew HewittSubscribe to MarketBeat All Access to unlock analyst rankingsInitiated CoverageBuy$6.00+92.31%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 07:43 AM ET. CLOV Forecast - Frequently Asked Questions What is Clover Health Investments' forecast for 2026? According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Clover Health Investments is $5.00, with a high forecast of $6.00 and a low forecast of $2.50. Should I buy or sell Clover Health Investments stock right now? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last twelve months. There is currently 1 sell rating, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CLOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares. Does Clover Health Investments's stock price have much upside? According to analysts, Clover Health Investments's stock has a predicted upside of 9.17% based on their 12-month stock forecasts. Has Clover Health Investments been upgraded by Wall Street analysts recently? Over the previous 90 days, Clover Health Investments's stock had 1 upgrade by analysts. What analysts cover Clover Health Investments? Clover Health Investments has been rated by research analysts at Deutsche Bank Aktiengesellschaft, Needham & Company LLC, UBS Group, Weiss Ratings, and Zacks Research in the past 90 days. Do Wall Street analysts like Clover Health Investments more than its competitors? Analysts like Clover Health Investments less than other "healthcare" companies. The consensus rating score for Clover Health Investments is 2.29 while the average consensus rating score for "healthcare" companies is 2.33. Learn more on how CLOV compares to other companies. Stock Forecasts and Research Tools Related Companies HQY Stock Forecast ALHC Stock Forecast UNH Stock Forecast ELV Stock Forecast HUM Stock Forecast CNC Stock Forecast MOH Stock Forecast OSCR Stock Forecast ENSG Stock Forecast HSIC Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With Clover Health Investments RecommendationsNeedham & Company LLCWeiss RatingsZacks ResearchDeutsche Bank AktiengesellschaftWall Street ZenUBS GroupCanaccord Genuity GroupLeerink Partners MarketBeat monitors more than a dozen sources for Clover Health Investments analyst ratings, with the most recent rating issued on 10/28/2026. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredMissed SpaceX’s 1,000% winner? Then this is for you…In 2024, SpaceX began ordering from a tiny supplier called Filtronic. Its stock has since climbed more than 1,...Brownstone Research | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredDO YOU LIVE HERE? ⬇️Data centers now number about 1,300 across the US, with another 2,500 planned. Each can draw as much power as ...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredTwo charts tell you the future…Gold miners are posting record cash flows, outperforming every other sector, yet mining still makes up just 1%...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clover Health Investments With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
